Check out our review on the role of #retroelements and #viralmimicry during cancer treatment! @neoviral.bsky.social

🚀 NY-CURES Launch — Championing State-Wide Investment in Science! 🚀 Our new coalition advocates for sustained public support of New York’s vibrant biomedical research ecosystem — creating cures, economic gains & strengthening communities. Sign up. Stay informed. Join the movement: www.nycures.org/

“Without the funding that went into developing CAR T-cell therapy, I and a lot of other kids would not be here today.” - Emily Whitehead. www.cnn.com/2025/03/07/h...

Today, in #PreprintClubHub1 Oxford’s Alfie Carter will present a #preprint about the way a bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodelling in immune competent preclinical models. ✌️🧠🐁 www.biorxiv.org/content/10.1...

Registration is now open for the next ImmunoSchool! This year’s theme: "10 Years of Discovery in Immunotherapy." We’ve put together a stellar lineup of speakers—don’t miss it! Free registration @ bit.ly/3WFj0Hc #ImmunoSchool #Immunotherapy #CancerResearch

Very proud of my Ph.D student Ashley who brilliantly defended her thesis last Friday!

👀 Read our preprint highlight w/ @natrevimmunol.bsky.social on in vivo enhancement of tumour-specific T cells via peptide–MHC-pseudotyped retroviral gene delivery 👇 www.nature.com/articles/s41...

#PreprintClub is now on Bluesky! Who are we and what are we doing? We are a group of enthusiastic scientists that gather together once a week to discuss fresh preprints in the field of #immunology. 🦠🧬